Add to ORKGStent thrombosis after drug eluting stent implantation has been reported to occur a few hours to over dozen months after the procedure and usually within the 4 weeks after discontinuation of antiplatelet medication. We present a case of a very late stent thrombosis which occurred 12 months after paclitaxel eluting stent implantation and four days after clopidogrel discontinuation despide aspirin continuation, and resulted in acute myocardial infarction. The patient was successfully treated with coronary angioplasty and was advised to use clopidogrel indefinitely. This case underlines the possible need for long term antiplatelet medication among patients receiving paclitaxel eluting stents
Although safety profiles of sirolimus-eluting stents do not seem to differ in short-to-medium term f...
Stent thrombosis is a rare but potentially fatal complication of percutaneous treatment of coronary ...
The risk of late thrombotic events and the need for prolonged dual antiplatelet therapy detract from...
Stent thrombosis after drug eluting stent implantation has been reported to occur a few hours to ove...
Drug-eluting stents (DES) present a slightly higher incidence of stent thrombosis compared to bare m...
We present a case of a very late stent thrombosis which occurred 13 months after drug-eluting stent ...
Antiplatelet therapy has become a standard primary and secondary prophylaxis regiment in cardiology....
Drug-eluting stents (DES) have a moderately higher incidence of stent thrombosis compared to bare me...
Four weeks' therapy with clopidogrel, in addition to aspirin (acetylsalicylic acid), is currently st...
he drug eluting stent (DES) has largely abolished the risk of in-stent restenosis and repeat revascu...
Drug-eluting stents (DESs) are the treatment of choice for obstructive coronary artery disease when ...
We present a case of a 47-year-old man with ST-segment-elevation myocardial infarction (STEMI), succ...
Although safety profiles of sirolimus-eluting stents do not seem to differ in short-to-medium term f...
Evidence indicates that very late stent thrombosis (<1 year) occurs more frequently in drug-eluting ...
Stent thrombosis (ST) is an uncommon but serious complication of percutaneous coronary intervention ...
Although safety profiles of sirolimus-eluting stents do not seem to differ in short-to-medium term f...
Stent thrombosis is a rare but potentially fatal complication of percutaneous treatment of coronary ...
The risk of late thrombotic events and the need for prolonged dual antiplatelet therapy detract from...
Stent thrombosis after drug eluting stent implantation has been reported to occur a few hours to ove...
Drug-eluting stents (DES) present a slightly higher incidence of stent thrombosis compared to bare m...
We present a case of a very late stent thrombosis which occurred 13 months after drug-eluting stent ...
Antiplatelet therapy has become a standard primary and secondary prophylaxis regiment in cardiology....
Drug-eluting stents (DES) have a moderately higher incidence of stent thrombosis compared to bare me...
Four weeks' therapy with clopidogrel, in addition to aspirin (acetylsalicylic acid), is currently st...
he drug eluting stent (DES) has largely abolished the risk of in-stent restenosis and repeat revascu...
Drug-eluting stents (DESs) are the treatment of choice for obstructive coronary artery disease when ...
We present a case of a 47-year-old man with ST-segment-elevation myocardial infarction (STEMI), succ...
Although safety profiles of sirolimus-eluting stents do not seem to differ in short-to-medium term f...
Evidence indicates that very late stent thrombosis (<1 year) occurs more frequently in drug-eluting ...
Stent thrombosis (ST) is an uncommon but serious complication of percutaneous coronary intervention ...
Although safety profiles of sirolimus-eluting stents do not seem to differ in short-to-medium term f...
Stent thrombosis is a rare but potentially fatal complication of percutaneous treatment of coronary ...
The risk of late thrombotic events and the need for prolonged dual antiplatelet therapy detract from...